Insider Transactions in Q4 2020 at Bio Rad Laboratories, Inc. (BIO)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2020
|
Dara Wright EVP, President, CDG |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-34.66%
|
$100,224
$576.72 P/Share
|
|
Dec 16
2020
|
Dara Wright EVP, President, CDG |
BUY
Exercise of conversion of derivative security
|
Direct |
502
+50.0%
|
-
|
|
Dec 15
2020
|
Michael Crowley EVP, GBL Commercial Operations |
SELL
Open market or private sale
|
Direct |
374
-9.25%
|
$216,920
$580.67 P/Share
|
|
Dec 07
2020
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
1,800
-0.1%
|
-
|
|
Dec 04
2020
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Indirect |
27
+0.21%
|
-
|
|
Dec 04
2020
|
Steven D Schwartz > 10% Shareholder |
BUY
Bona fide gift
|
Direct |
27
+0.11%
|
-
|
|
Dec 04
2020
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
27
+0.21%
|
-
|
|
Dec 04
2020
|
Norman D Schwartz Chairman & CEO |
BUY
Bona fide gift
|
Direct |
27
+0.01%
|
-
|
|
Dec 04
2020
|
Alice N Schwartz > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
162
-0.04%
|
-
|
|
Nov 09
2020
|
Annette Tumolo Executive Vice President |
SELL
Bona fide gift
|
Direct |
423
-10.26%
|
-
|
|
Nov 06
2020
|
Annette Tumolo Executive Vice President |
SELL
Open market or private sale
|
Direct |
1,200
-8.05%
|
$768,000
$640.64 P/Share
|
|
Nov 06
2020
|
Annette Tumolo Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+18.4%
|
$190,800
$159.32 P/Share
|